Anacor Pharmaceuticals, Inc. 4/A SEC Filings

Filed On	Filing
12 Nov 2015	Form 4/A: Hove Anders D, Director Disposed of 1,399,705 shares (Other Transaction) · Acquired 372,982 shares (Other Transaction)
21 Oct 2014	Form 4/A: Hove Anders D, Director Granted 0 2.00% Convertible Senior Notes due 2021
06 Jun 2014	Form 4/A: Leschly Mark, Director Acquired 13,067 shares (Other Transaction)
25 Sep 2012	Form 4/A: Maples Kirk R, SVP, Program Management Sold 3,000 shares ($18.1K)

Comments